SCHEMBL8285193

SCHEMBL8285193

Cc1cc(C(=O)c2ccc(F)cc2)nc2c1c(=O)cc(Nc1ccccc1)n2-c1ccccc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE11A Q9HCR9 1/20 0.44
RAB9A P51151 6/20 0.42
NPC1 O15118 5/20 0.42
MEN1 O00255 4/20 0.42
KMT2A Q03164 4/20 0.42
KDR P35968 1/20 0.38
CCNA2 P20248 1/20 0.38
CDK2 P24941 1/20 0.38
GAA P10253 1/20 0.37
GFER P55789 1/20 0.37
MAPT P10636 5/20 0.37
ALDH1A1 P00352 4/20 0.37
KDM4E B2RXH2 3/20 0.37
ADORA3 P0DMS8 1/20 0.37
ADORA2A P29274 1/20 0.37
ADORA1 P30542 1/20 0.37
LMNA P02545 1/20 0.37
CRHBP P24387 1/20 0.37
CRHR2 Q13324 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8285169 0.93 PDE11A (0.45) PDE11ARAB9ANPC1MEN1KMT2A
SCHEMBL8285220 0.91 PDE11A (0.43) PDE11ARAB9ANPC1MEN1KMT2A
SCHEMBL8285205 0.90 MAPT (0.44) PDE11ARAB9ANPC1MEN1KMT2A
SCHEMBL5872175 0.86 PDE11A (0.47) PDE11AGAAGFERMAPTALDH1A1
SCHEMBL8285185 0.85 CSNK2A2 (0.39) PDE11AKDRALDH1A1ADORA3ADORA2A
SCHEMBL5871541 0.85 PDE11A (0.46) PDE11ARAB9ANPC1GAAGFER
SCHEMBL8287397 0.84 PDE11A (0.46) PDE11ARAB9ANPC1GAAGFER
SCHEMBL8287107 0.84 PDE11A (0.48) PDE11ARAB9ANPC1MEN1KMT2A
SCHEMBL8287393 0.84 PDE11A (0.46) PDE11ARAB9ANPC1KDRMAPT
SCHEMBL8285223 0.82 PDE11A (0.44) PDE11AGAAGFERMAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005091857-A2 1,6-NAPHTHYRIDINE AND 1,8-NAPHTHYRIDINE DERIVATIVES AND THEIR USE TO TREAT DIABETES AND RELATED DISORDERS BAYER PHARMACEUTICALS CORPORATION (US) 2005-10-06 WO disclosed